Navigation Links
Sangamo BioSciences Reports Third Quarter 2009 Financial Results
Date:11/4/2009

program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Sangamo also has two Phase 1 clinical trials to evaluate safety and clinical effect of a ZFP Therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN) for gene modification. Sangamo has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's web site at http://www.sangamo.com/.

This press release contains forward-looking statements regarding Sangamo's current expectations. These forward looking statements include, without limitation, references to the research and development of ZFP TFs and ZFNs, clinical trials of SB-509 and SB-728-T, therapeutic and non-therapeutic applications of Sangamo's ZFP technology platform, eligibility to receive royalty and milestone payments under the Sigma agreement, strategic partnership with collaborators and anticipated amount of cash and cash equivalents. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, the early stage of ZFP Therapeutic development, uncertainties related to th
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
3. Sangamo BioSciences Reports First Quarter 2009 Financial Results
4. Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference
5. Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
6. Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting
7. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
8. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
9. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
10. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
11. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... flu season approaches, the best way to stay healthy ... and a checkup, according to an infectious disease specialist. ... against the flu, and also address other health concerns ... flu shots for their customers, but they can,t dole ... of infection prevention and control for the Loyola University ...
(Date:9/20/2014)... New York, New York (PRWEB) September 20, 2014 ... of power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in ... notes that yet another insurer has announced plans ... a statement posted on its website last month, ... such procedures effective November 1, 2014. The insurer ...
(Date:9/20/2014)... 20, 2014 Traditionally dentists have advised their ... South Charlotte Dentistry is re-visiting that advice and changing ... that coffee and wine have on oral health. “There’s good ... that coffee may be beneficial in protecting against gum disease, ... The study on coffee was from the September 2014 ...
(Date:9/20/2014)... NY (PRWEB) September 20, 2014 Earlier this ... their customers may have had their credit card information pilfered ... year, spawning a slew of headline articles like this ... weren’t the only eye opening numbers. , “Most people ... stolen, almost like it’s a way to score a game,” ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Arizona ... College (MCC) is celebrating National Manufacturing Day by opening ... enhanced machining, processing and additive manufacturing labs will be ... 3, 2014 at MCC’s Southern and Dobson campus (1833 ... in southeast Lot D. , The AzAMI at MCC ...
Breaking Medicine News(10 mins):Health News:Get a Flu Shot During Checkup, Doctor Says 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2
... , ... on the Practice Turf of Physicians? A Study Commissioned by Jackson & Coker Offers an ... Alpharetta, GA ... health care -- compounded with the shortage of physicians in major medical specialties -- the ...
... , ... its second flagship location as part of its national expansion plan revolutionizing the ... fitness, while Throwdown®, one of the leading brands in action and impact sports, debuts ... ...
... of what makes those relationships so golden during the ... more likely to forgive and respect one,s elders, according ... better marriages, more supportive friendships and less conflict with ... in Gerontology, Developmental and Family Studies. "While physical and ...
... HealthDay Reporter , THURSDAY, June 24 (HealthDay News) -- Diabetes ... attack, stroke or other heart condition, a new study finds. ... deaths from cardiovascular disease, or about 325,000 deaths a year ... people with diabetes are more likely to have heart attacks," ...
... ... Tests, including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations , ... Valencia, CA (PRWEB) June 25, 2010 ... and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of ...
... ... at providing resources that will educate staff to make positive choices aimed at optimizing ... ... Company for carriers, service providers, VARs, and equipment manufacturers, is pleased to announce a ...
Cached Medicine News:Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 2Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 3Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 4Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 5Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 6Health News:Throwdown, a Leader in Impact and Action Sports, Debuts Latest Innovations at the Newest UFC Gym™ in Rosemead, California 2Health News:Throwdown, a Leader in Impact and Action Sports, Debuts Latest Innovations at the Newest UFC Gym™ in Rosemead, California 3Health News:Throwdown, a Leader in Impact and Action Sports, Debuts Latest Innovations at the Newest UFC Gym™ in Rosemead, California 4Health News:Throwdown, a Leader in Impact and Action Sports, Debuts Latest Innovations at the Newest UFC Gym™ in Rosemead, California 5Health News:Friendships, family relationships get better with age thanks to forgiveness, stereotypes 2Health News:Friendships, family relationships get better with age thanks to forgiveness, stereotypes 3Health News:Diabetes May Double Risk of Heart Attack, Stroke 2Health News:Diabetes May Double Risk of Heart Attack, Stroke 3Health News:TB Claims One Life Every 17 Seconds; Almost Two Million People Each Year 2Health News:TB Claims One Life Every 17 Seconds; Almost Two Million People Each Year 3Health News:Endeavor Telecom Introduces Upgraded Company Health Initiative to Encourage Healthy Lifestyle Choices 2
(Date:9/19/2014)... 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... and approved all parts required to build nine ... to manufacture the new PCT-based instrument system.  The ... for shipment by mid-October and that additional Barozyme ... rate of about one per week thereafter.  ...
(Date:9/19/2014)... , Sept. 19, 2014  The body of ... the publication of two papers this past week.  The ... Head and Neck Surgery , finds that withholding ... subjective measures of sleep disordered breathing, leading the paper,s ... in obstructive sleep apnea severity and improvement of quality ...
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
Baby Weitlaner retractor, blunt, 4"....
Daubenspeck sharp curette, 8....
MRI curette, 8.5" overall length....
9.5" overall length, 4.5" handle....
Medicine Products: